BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 12580846)

  • 41. [French pathologist' implication in cervical cancer screening].
    Vacher-Lavenu MC
    Ann Pathol; 2006 Oct; 26(5):369-74. PubMed ID: 17255925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An objective quality assurance method for the solo cytopathologist.
    Stump MM
    Qual Assur Util Rev; 1986 Aug; 1(3):79-82. PubMed ID: 2980882
    [No Abstract]   [Full Text] [Related]  

  • 43. Automated cervical cancer screening: apprehension or logic--which will it be?
    Wilbur DC
    Diagn Cytopathol; 1999 Oct; 21(4):235-7. PubMed ID: 10495314
    [No Abstract]   [Full Text] [Related]  

  • 44. Effectiveness of cervical cancer screening at age 65 - A register-based cohort study.
    Pankakoski M; Anttila A; Sarkeala T; Heinävaara S
    PLoS One; 2019; 14(3):e0214486. PubMed ID: 30913262
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multilevel interventions: measurement and measures.
    Charns MP; Foster MK; Alligood EC; Benzer JK; Burgess JF; Li D; McIntosh NM; Burness A; Partin MR; Clauser SB
    J Natl Cancer Inst Monogr; 2012 May; 2012(44):67-77. PubMed ID: 22623598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of type of screening laboratory on population-based occurrence of cervical lesions in Finland.
    Nieminen P; Hakama M; Tarkkanen J; Anttila A
    Int J Cancer; 2002 Jun; 99(5):732-6. PubMed ID: 12115508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Computer-assisted screening for cervical carcinoma--the results for a 10-year period].
    Neumann HG; Seidenschnur G
    Arch Geschwulstforsch; 1987; 57(2):129-39. PubMed ID: 3296989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Six years' audit of laboratory workload and rates of referral for colposcopy in a cervical screening programme in three districts.
    Raffle AE; Alden B; Mackenzie EF
    BMJ; 1990 Oct; 301(6757):907-11. PubMed ID: 2261537
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
    Ivanov S
    Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quality improvement project in cervical cancer screening: practical measures for monitoring laboratory performance.
    Tarkkanen J; Geagea A; Nieminen P; Anttila A
    Acta Obstet Gynecol Scand; 2003 Jan; 82(1):82-8. PubMed ID: 12580846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Status of screening tests for cervical cancer and its precancerous lesion].
    Zhao FH; Rong SD; Qiao YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):638-41. PubMed ID: 12901114
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.